Radiologic Response Combined with Dermatologic Toxicities is the Most Robust Predictor of Survival Benefits in Patients with Inoperable Hepatocellular Carcinoma After Transarterial Chemoembolization Plus Sorafenib Therapy

PURPOSE: The survival benefits of patients with inoperable hepatocellular carcinoma (HCC) who undergo transarterial chemoembolization (TACE) and receive sorafenib therapy remain controversial. We aimed to identify clinical predictors in patients with inoperable HCC undergoing TACE and receiving sora...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Zhiqiu, Deng, Zhizhen, Jiang, Suxiang, Wang, Tang, Liu, Long, Jiang, Kuiming, Zhang, Yingqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Clinical Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8382652/
https://www.ncbi.nlm.nih.gov/pubmed/33948697
http://dx.doi.org/10.1007/s00270-021-02846-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8382652/
https://www.ncbi.nlm.nih.gov/pubmed/33948697
http://dx.doi.org/10.1007/s00270-021-02846-w

Ejemplares similares